NeOnc Technologies Holdings, Inc. (NTHI)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	282.00M
Revenue (ttm)	90,462
Net Income (ttm)	-9.83M
Shares Out	22.56M
EPS (ttm)	-0.44
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About NTHI

NeOnc Technologies (f/k/a NAS-ONC, Inc.) was formed in 2008, devoted to developing new drugs with new delivery modes. As a clinical-stage biopharmaceutical company, we have focused on establishing treatments for intracranial malignancies, i.e., aggressive cancers located in the brain. These cancer types include primary brain cancers, such as glioblastoma, and secondary brain cancers, that have arrived through metastatic spread from other cancers throughout the body, such as melanoma or breast and lung cancer. Brain-localized malignancies are pa...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 8
• Stock Exchange: NASDAQ
• Ticker Symbol: NTHI
• Website: https://neonctech.com/